ADMA

8.48

2.54% 0.21

Dopo l'orario di chiusura: 8.52 0.04 +0.47%

Adma Biologics Inc (ADMA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$8.27

Aprire:

$8.38

Volume 24 ore:

2.39M

Relative Volume:

0.54

Capitalizzazione di mercato:

$1.97B

Reddito:

$509.86M

Utile/perdita netta:

$165.35M

Rapporto P/E:

12.51

EPS:

0.6779

Flusso di cassa netto:

$107.55M

1 W Prestazione:

-3.09%

1M Prestazione:

-3.09%

6M Prestazione:

-48.85%

1 anno Prestazione:

-52.92%

Intervallo 1D:

$8.35

$8.62

Intervallo di 1 settimana:

$8.165

$8.755

Portata 52W:

$7.2101

$20.46

Adma Biologics Inc Stock (ADMA) Company Profile

Nome

Adma Biologics Inc

Settore

Healthcare (1074)

Industria

Biotechnology (599)

Telefono

(201) 478-5552

Indirizzo

C/O ADMA BIOLOGICS, INC., RAMSEY

Dipendente

647

Cinguettio

@AdmaBiologics

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

ADMA's Discussions on Twitter

Compare ADMA vs VRTX, REGN, ARGX, RVMD, ALNY

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADMA Adma Biologics Inc	8.48	1.92B	509.86M	165.35M	107.55M	0.6779
VRTX Vertex Pharmaceuticals Inc	479.00	121.16B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	667.17	68.78B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	888.82	57.44B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	188.07	40.23B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	278.40	36.28B	4.29B	577.22M	641.34M	4.2086

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-21	Iniziato	Canaccord Genuity	Buy
2026-03-26	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-07-19	Ripresa	Raymond James	Strong Buy
2022-10-13	Iniziato	Mizuho	Buy
2021-11-11	Aggiornamento	Raymond James	Outperform → Strong Buy
2021-11-09	Iniziato	Cantor Fitzgerald	Overweight
2019-06-04	Iniziato	Jefferies	Buy
2019-04-15	Reiterato	H.C. Wainwright	Buy
2019-02-07	Ripresa	H.C. Wainwright	Buy
2017-12-11	Reiterato	Maxim Group	Buy
2017-11-14	Aggiornamento	Raymond James	Mkt Perform → Outperform
2017-01-23	Aggiornamento	Maxim Group	Hold → Buy
2016-08-01	Downgrade	Maxim Group	Buy → Hold
2016-07-25	Reiterato	Maxim Group	Buy
2015-05-13	Reiterato	Maxim Group	Buy
2014-12-08	Iniziato	Oppenheimer	Outperform
2014-12-01	Reiterato	Maxim Group	Buy

Mostra tutto

Adma Biologics Inc Borsa (ADMA) Ultime notizie

12:02 PM

DEADLINE ALERT for VIA, Z, ADMA, and ERAS: The Law Offices - GlobeNewswire

12:02 PM

12:00 PM

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV

12:00 PM

10:13 AM

ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff - GlobeNewswire

10:13 AM

10:00 AM

Did You Lose Money Investing in ADMA Biologics, Inc. - GlobeNewswire

10:00 AM

09:39 AM

ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed - Morningstar

09:39 AM

08:55 AM

AUGUST 10, 2026 DEADLINE: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead ADMA Investor Class Action Lawsuit - TMX Newsfile

08:55 AM

07:36 AM

$ADMA Lawsuit Notice: BFA Law Reminds ADMA Biologics - GlobeNewswire

07:36 AM

Jul 26, 2026

August 10, 2026 Deadline Approaching: Join Class Action Against ADMA Biologics, Inc. (ADMA) – Contact Levi & Korsinsky - ACCESS Newswire

Jul 26, 2026

Jul 25, 2026

ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - Stocktwits

Jul 25, 2026

Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Before August 10, 2026 to Join Class Action - ACCESS Newswire

Jul 25, 2026